DEA Schedule CII

Strength

2.5; 2.5; 2.5; 2.5 mg/1; mg/1; mg/1; mg/1

Manufacturer

Epic Pharma LLC

NDC

42806034101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA040444

On Market Since

3/15/2019

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-2.9%

3M

-5.9%

6M

+1.5%

1Y

-16.7%

3Y

-28.7%

5Y

-14.9%

All

-40.1%